Linehan WM - Search Results

1

Targeting the mTOR pathway in Chromophobe Kidney Cancer.

Shuch B, Vourganti S, Friend JC, Zehngebot LM, Linehan WM, Srinivasan R. Shuch B, et al. Among authors: linehan wm. J Cancer. 2012;3:152-7. doi: 10.7150/jca.4378. Epub 2012 Apr 2. J Cancer. 2012. PMID: 22481981 Free PMC article.

2

Fine-needle aspiration of metastatic clear cell carcinoma of the kidney: employment of microdissection and the polymerase chain reaction as a potential diagnostic tool.

Beaty MW, Zhuang Z, Park WS, Emmert-Buck MR, Linehan WM, Lubensky IA, Abati A. Beaty MW, et al. Among authors: linehan wm. Cancer. 1997 Jun 25;81(3):180-6. Cancer. 1997. PMID: 9196017

3

VHL-mediated hypoxia regulation of cyclin D1 in renal carcinoma cells.

Bindra RS, Vasselli JR, Stearman R, Linehan WM, Klausner RD. Bindra RS, et al. Among authors: linehan wm. Cancer Res. 2002 Jun 1;62(11):3014-9. Cancer Res. 2002. PMID: 12036906

4

The contribution of VHL substrate binding and HIF1-alpha to the phenotype of VHL loss in renal cell carcinoma.

Maranchie JK, Vasselli JR, Riss J, Bonifacino JS, Linehan WM, Klausner RD. Maranchie JK, et al. Among authors: linehan wm. Cancer Cell. 2002 Apr;1(3):247-55. doi: 10.1016/s1535-6108(02)00044-2. Cancer Cell. 2002. PMID: 12086861 Free article.

5

Prior chemotherapy and allograft CD34+ dose impact donor engraftment following nonmyeloablative allogeneic stem cell transplantation in patients with solid tumors.

Carvallo C, Geller N, Kurlander R, Srinivasan R, Mena O, Igarashi T, Griffith LM, Linehan WM, Childs RW. Carvallo C, et al. Among authors: linehan wm. Blood. 2004 Feb 15;103(4):1560-3. doi: 10.1182/blood-2003-04-1170. Epub 2003 Oct 9. Blood. 2004. PMID: 14551148 Free article.

6

Focus on kidney cancer.

Linehan WM, Zbar B. Linehan WM, et al. Cancer Cell. 2004 Sep;6(3):223-8. doi: 10.1016/j.ccr.2004.09.006. Cancer Cell. 2004. PMID: 15380513 Free article. Review. No abstract available.

7

Genetic basis of cancer of the kidney: disease-specific approaches to therapy.

Linehan WM, Vasselli J, Srinivasan R, Walther MM, Merino M, Choyke P, Vocke C, Schmidt L, Isaacs JS, Glenn G, Toro J, Zbar B, Bottaro D, Neckers L. Linehan WM, et al. Clin Cancer Res. 2004 Sep 15;10(18 Pt 2):6282S-9S. doi: 10.1158/1078-0432.CCR-050013. Clin Cancer Res. 2004. PMID: 15448018 Review.

8

Targeted for destruction: the molecular basis for development of novel therapeutic strategies in renal cell cancer.

Srinivasan R, Linehan WM. Srinivasan R, et al. Among authors: linehan wm. J Clin Oncol. 2005 Jan 20;23(3):410-2. doi: 10.1200/JCO.2005.09.907. Epub 2004 Nov 30. J Clin Oncol. 2005. PMID: 15572728 No abstract available.

9

Topotecan blocks hypoxia-inducible factor-1alpha and vascular endothelial growth factor expression induced by insulin-like growth factor-I in neuroblastoma cells.

Beppu K, Nakamura K, Linehan WM, Rapisarda A, Thiele CJ. Beppu K, et al. Among authors: linehan wm. Cancer Res. 2005 Jun 1;65(11):4775-81. doi: 10.1158/0008-5472.CAN-04-3332. Cancer Res. 2005. PMID: 15930297

10

HIF overexpression correlates with biallelic loss of fumarate hydratase in renal cancer: novel role of fumarate in regulation of HIF stability.

Isaacs JS, Jung YJ, Mole DR, Lee S, Torres-Cabala C, Chung YL, Merino M, Trepel J, Zbar B, Toro J, Ratcliffe PJ, Linehan WM, Neckers L. Isaacs JS, et al. Among authors: linehan wm. Cancer Cell. 2005 Aug;8(2):143-53. doi: 10.1016/j.ccr.2005.06.017. Cancer Cell. 2005. PMID: 16098467 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

816 results

Search Page

Filters